Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-07-06 00:00:00 ET · period of report 2023-07-06 · accession 0001415889-23-010905 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-06 | 2023-07-06 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $0.96 | +5,280 | 34.1K | +18% | +$5,069 |
| D | 2023-07-06 | 2023-07-06 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $8.47 | -2,207 | 28.8K | -7% | -$18.7K |
| D | 2023-07-06 | 2023-07-06 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $0.96 | -5,208 | 204.0K | -2% | -$5,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-07-06 | M | A | 5,280 | $0.96 | 34,106 | D | — | — | (F2) Shares acquired through the exercise of an option contract with strike price of $0.96 and an expiration date of August 6, 2023. |
| 2 | Common | Common Shares | 2023-07-06 | S | D | 2,207 | $8.47 | 28,826 | D | — | — | (F1) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Derivative | Common Shares | 2023-07-06 | M | D | 5,208 | $0.96 | 203,978 | D | $0.96 · 2013-08-06 to 2023-08-06 | 5,208 Options | (F3) Represents options granted on August 6, 2013, with a strike price of $0.96 and expiration date of August 6, 2023. |